Jiuang Mao

机构：Tongren Hospital

发表论文 9 篇 · 总被引 30 次 · h-index 4

代表论文

Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy (2024 · Cancer Immunology Immunotherapy · 被引 11)
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisons (2022 · British Journal of Radiology · 被引 7)
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial (2024 · Radiation Oncology · 被引 4)
Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status (2022 · Cancer Medicine · 被引 4)
Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy (2022 · Cancers · 被引 3)
Predictive role of inflammatory markers for the efficacy of first-line immunotherapy plus chemotherapy in advanced gastric cancer (2025 · Discover Oncology · 被引 1)